SINCLAIR IS PHARMA |
Precio de cierre
Otros sitios de cotización
|
||
| - EUR | - |
|
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Miguel Pardos
CEO | Chief Executive Officer | - | 01/06/22 |
Santiago Calavia
PRN | Corporate Officer/Principal | - | - |
Julie Moreau
PRN | Corporate Officer/Principal | - | - |
Kamal Abbasi
PRN | Corporate Officer/Principal | - | - |
Jayne Burrell
LAW | General Counsel | 50 | 02/01/15 |
Nairn McMaster
PRN | Corporate Officer/Principal | - | 01/07/11 |
Emilie Croissant
SAM | Sales & Marketing | - | - |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
Cheng Wei Liu
CHM | Chairman | 50 | - |
Miguel Pardos
CEO | Chief Executive Officer | - | 01/06/22 |
Gen Li
BRD | Director/Board Member | - | 27/04/23 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 580 157 084 | 315 849 061 ( 54,44 %) | 0 | 54,44 % |
Información de la empresa
Sinclair Pharma Ltd.
Whitfield Court 30-32 Whitfield Street
W1T 2RQ, London
+44 20 7467 6920
http://www.sinclairpharma.com
Sector
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| +21,98 % | 43,92 mil M | |
| +24,56 % | 23,09 mil M | |
| +19,25 % | 15,35 mil M | |
| +14,03 % | 13,61 mil M | |
| +46,40 % | 12,02 mil M | |
| -10,14 % | 6997,21 M | |
| -0,05 % | 6787,61 M | |
| -8,87 % | 5725,52 M | |
| +13,07 % | 5596,79 M |
- Bolsa de valores
- Acciones
- Acción
- Acción
- Empresa SINCLAIR IS PHARMA
